InVivo Therapeutics to Present at the OneMedForum Conference on July 12th in NYC

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, InVivo Therapeutics Chief Executive Officer, will present at the OneMedForum Conference at 1:30 pm EST on July 12th in New York City at the Metropolitan Club in the Morton Room. A live webcast of this presentation will be available at http://www.onemedplace.com/forum/.

For full event details and registration information, please visit http://www.onemedplace.com/forum/.

About OneMedForum

OneMedPlace Trans-Atlantic Conference is the definitive conference in North America for fast-growing and emerging healthcare and life sciences companies. The 3rd annual New York Conference will bring together these emerging companies with venture and strategic investors within a unique networking and educational forum. Thought leaders in the disruptive technologies space across a variety of healthcare divisions will present both strategic insights and investment ideas to an international audience of the industrys movers and shakers.

This year, OneMedPlace explores the exciting investment opportunities, challenges and forward looking strategies in four sectors on the cusp of significant change: - Diagnostics - Health Information - Oncology - Regenerative Medicine.

The OneMedForum NY was recognized by Mayor Michael R. Bloomberg as an important event supporting innovation in the healthcare and life science industries giving them the support, guidance and information they need to raise capital and develop innovative new ideas. Bloomberg proclaimed June 29th-30th in the city of New York as OneMedForum Days.

About InVivo Therapeutics

InVivo Therapeutics Holdings Corp. is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD. Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital. In 2011, the company earned the prestigious David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. The publicly traded company is headquartered in Cambridge, Mass. For more details, visit http://www.invivotherapeutics.com.

Safe Harbor Statement

Read more:
InVivo Therapeutics to Present at the OneMedForum Conference on July 12th in NYC